 |
 |

Growth Hormone Responses to the Stimulation of Hypothalamic Glucoreceptors in Diabetic RetinopathyEffects of Catecholamine Precursors and Dopamine Antagonists
Claude Schaub, MD;
Pierre Drouin, MD;
Marie-Thérése Bluet-Pajot, PhD;
Luc Mejean, PhD;
Daniel Rousselle, MD
Arch Neurol. 1982;39(5):264-269.
Abstract
 |  |
The effects of the stimulation of glucoreceptors located at the level of the lateral hypothalamic nuclei and sensitive to intracellular glucose deprivation on growth (GH) release are well documented in the monkey. In this study the effect of a reproducible hypoglycemic stimulatory procedure was controlled by continuously monitoring blood glucose (BG) levels in normal subjects and in a series of 120 diabetic patients. In contrast to control subjects, GH responses to similar hypoglycemic nadirs were not reproducible in diabetics (with or without diabetic retinopathy). The infusion of levodopa, precursor of both norepinephrine (NE) and dopamine, during BG decline rendered the GH response to hypoglycemia consistently reproducible. To investigate the site of action of levodopa, a group of diabetics were pretreated with a centrally active dopamine antagonist, metoclopramide hydrochloride. The pattern of GH release was similar in both groups. These data suggest that in diabetes the interaction of levodopa and adequate stimulation of hypothalamic glucoreceptor systems is mediated by an NE transmission.
Author Affiliations
From the Laboratory of Clinical and Experimental Neurosurgical Neuroendocrinology, Neuroendocrinology Unit, National Institute of Health and Medical Research, Paris (Drs Schaub and Bluet-Pajot), and Unit of Nutrition and Diet Research, National Institute of Health and Medical Research, Nancy, France (Drs Drouin, Mejean, and Rousselle).
Footnotes
Accepted for publication April 17, 1981.
Reprint requests to U.159 INSERM, 2ter, rue d'Alésia, 75014 Paris, France (Dr Schaub).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|